0
Home
Products
Inquiry
Career
Who We Are
What We Are
Investors
Financial Information
Restated Financials Dec’23
Financials 2021
Financials 2022
Financials 2023
Interim Financials Dec’23
Financials 2024
Interim Financials Sep’24
Restated Financials Sep’24
Annual Report
Annual Reports
FY 2018-19
FY 2019-20
FY 2020-21
FY 2021-22
FY 2022-23
FY 2023-24
MGT-7
FY 2018-19
FY 2019-20
FY 2020-21
FY 2021-22
FY 2022-23
FY 2023-24
Investor Information
Corporate Governance
Corporate Governance
Board of Directors
KMP
SMP
Committee of Board of Directors
Policies
Archival Policy
Board Diversity Policy
Code of Conduct - Policy
Code of Fair Disclosure of Unpublished Price Sensitive Information
Corporate Governance
Familiarisation_Programme
Insider Trading Policy
Materiality Policies for group company, Creditors, Litigation
Nomination and Remuneration Policy
Policy and Procedures for Inquiry in Case of Leak or Suspected Leak of UPSI
Policy on Dealing with Related Party Transactions
Policy on Preservation of Documents
Policy on Materiality events
Risk Assessment and Management Policy
Terms and Conditions of Appointment of Independent Directors
Vigil Mechanism & Whistle Blower Policy
Sexual Harassment
Others
Material Contract
Tripartite Agreement
NSDL
CDSL
RTA Agreement
Offer Agreement
Market Maker Agreement
Underwriter Agreement
Syndicate Agreement
Share Escrow Agreement
Public Offer Agreement
Material Documents
Examination report of Independent Auditor on Restated Financials
Material Creditors
Management Team Information
Consents
Promoters
Directors
Selling shareholders
Book Running Lead Manager
Registrar to the Offer
Bankers of the Company
Company Secretary & Compliance Officer
Chief Financial Officer
Legal Counsel
MOA & AOA
COI
25-Jan-2024
21-Aug-2017
Authorization letter from selling shareholders
Carrying & Forwarding Agency Agreement
Due Diligence Certificate
IPO
DRHP
RHP
Prospectus
Resolutions
Special resolution for Increase of Authorised Capital
Board resolution for approval and adoption of DRHP
Board resolution for approval and adoption of KPIs
Board resolution for approval of consent from selling shareholders
Special Resolution for Appointment of Managing Director
Board resolution for Appointment of Managing Director
Contact Us
Login
Register
Anti Histaminics
All Category
Anti Histaminics
AVERTICH M TABLETS
115.00
Add To Cart
View Details
EAZEURT -25 TABLETS
65.00
Add To Cart
View Details
EAZEURT -10 TABLETS
32.00
Add To Cart
View Details
URTIBIL 40 TABLETS
190.00
Add To Cart
View Details
HISTOCROSS 180 TABS
155.00
Add To Cart
View Details
HISTOCROSS L TABS 10MG
65.00
Add To Cart
View Details
HISTACROSS-L TABS 5 MG
55.00
Add To Cart
View Details
AMVIBAST-20 TABLETS
85.00
Add To Cart
View Details
AVERTICH TABLETS
68.00
Add To Cart
View Details
1
2
Next
Back To Product Category
Chat With Us On Instagram
